IAM
IDXX icon

Impax Asset Management’s Idexx Laboratories IDXX Stock Holding History

Impax Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$224K Buy
+1,030
New +$212K 0.01% 197

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FEF
Fundsmith Equity Fund Stamford, Connecticut $13.4B AUM
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Impax Asset Management's IDXX Position: Q2 2018 in Review

Impax Asset Management opened a new position in Idexx Laboratories (IDXX) in Q2 2018: 1,030 shares worth $224K. The stake represents 0.01% of the portfolio and ranks #197 among its holdings.

664 funds tracked by Wall St. Rank hold IDXX as of Q2 2018.

  • Impax Asset Management held 1,030 shares of Idexx Laboratories worth $224K as of Q2 2018.
  • Idexx Laboratories was a new Impax Asset Management position in Q2 2018.
  • Idexx Laboratories made up 0.01% of Impax Asset Management's portfolio in Q2 2018, its #197 holding.
  • 664 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2018.

Based on Impax Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.